Euclid Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-37,350
| Closed | -$2.31M | – | 28 |
|
|
2016
Q2 | $2.31M | Sell |
37,350
-17,771
| -32% | -$1.1M | 0.1% | 258 |
|
|
2016
Q1 | $3.15M | Sell |
55,121
-82,988
| -60% | -$4.74M | 0.12% | 230 |
|
|
2015
Q4 | $8.18M | Buy |
+138,109
| New | +$8.18M | 0.25% | 142 |
|
|
2015
Q3 | – | Sell |
-127,837
| Closed | -$8.59M | – | 225 |
|
|
2015
Q2 | $8.59M | Sell |
127,837
-451,373
| -78% | -$30.3M | 0.17% | 191 |
|
|
2015
Q1 | $33.9M | Buy |
+579,210
| New | +$33.9M | 0.62% | 35 |
|
|
2014
Q4 | – | Sell |
-809,400
| Closed | -$46.8M | – | 373 |
|
|
2014
Q3 | $46.8M | Buy |
809,400
+54,200
| +7% | +$3.13M | 0.34% | 65 |
|
|
2014
Q2 | $42.6M | Sell |
755,200
-121,578
| -14% | -$6.86M | 0.3% | 75 |
|
|
2014
Q1 | $45.1M | Buy |
876,778
+239,400
| +38% | +$12.3M | 0.34% | 64 |
|
|
2013
Q4 | $33.7M | Sell |
637,378
-29,000
| -4% | -$1.53M | 0.28% | 77 |
|
|
2013
Q3 | $29.8M | Buy |
666,378
+137,528
| +26% | +$6.15M | 0.3% | 74 |
|
|
2013
Q2 | $21.9M | Buy |
+528,850
| New | +$21.9M | 0.28% | 82 |
|